🚀 Exciting Collaboration Announcement! 🚀
April 28, 2025
We at
Pharmidex have been delighted to collaborate closely with the talented teams at
Apeikon Therapeutics and
King's College London to generate exciting new data in the field of oncology research.
We are proud to share that our collaborative poster will be presented this afternoon at the AACR Annual Meeting 2025 in Chicago! 🇺🇸✨
📄 Check out the poster and learn more here:
https://lnkd.in/e7-TVBB9
A huge thank you to everyone involved for making this project a success, we are looking forward to continuing to push the boundaries of discovery together!
If you're attending AACR, come and visit, we would love to discuss our findings and explore new opportunities for collaboration.
#Pharmidex #AACR2025 #Collaboration #OncologyResearch #DrugDiscovery #TranslationalResearch #Teamwork #Innovation
At Pharmidex , we deliver high-quality LC-MS bioanalysis to support drug development across a wide range of analysis. Our experienced team supports preclinical, translational and clinical studies, providing accurate, reliable data under GLP and GCP to help drive confident decision-making. Learn more about our LC-MS capabilities: https://www.pharmidex.com/Discovery-Bioanalysis
Pharmidex offers high-quality Clinical Chemistry services delivering accurate, reliable data to support drug development. Our expert team and robust, quality-driven workflows enable trusted results that help accelerate decision-making and strengthen collaboration with pharma companies, CROs and academic partners. By working together, we support better science and more efficient drug development. 👉 Learn more: https://www.pharmidex.com/Clinical-chemistry
Pharmidex is delighted to share that Ash Alavijeh , Head of Operations, will be attending the UK BioIndustry Association (BIA) Annual Gala Dinner at the Roundhouse, London. Ash is looking forward to connecting with pharma and biotech colleagues to explore new collaborations, partnerships, and opportunities, all with the shared goal of advancing drug discovery and development. If you’re attending, feel free to connect with Ash this evening.
